日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial

磷脂酰丝氨酸靶向抗体 Bavituximab 联合 Pembrolizumab 治疗不可切除的肝细胞癌:一项 2 期临床试验

David Hsiehchen #, Muhammad S Beg #, Radhika Kainthla, Jay Lohrey, Syed M Kazmi, Leticia Khosama, Mary Claire Maxwell, Heather Kline, Courtney Katz, Asim Hassan, Naoto Kubota, Ellen Siglinsky, Anil K Pillai, Hagop Youssoufian, Colleen Mockbee, Kerry Culm, Mark Uhlik, Laura Benjamin, Rolf A Brekken, 

Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway

伊曲康唑通过抑制 HER2/AKT 信号通路发挥对食管癌的抗肿瘤作用

Wei Zhang, Ankur S Bhagwath, Zeeshan Ramzan, Taylor A Williams, Indhumathy Subramaniyan, Vindhya Edpuganti, Raja Reddy Kallem, Kerry B Dunbar, Peiguo Ding, Ke Gong, Samuel A Geurkink, Muhammad S Beg, James Kim, Qiuyang Zhang, Amyn A Habib, Sung-Hee Choi, Ritu Lapsiwala, Gayathri Bhagwath, Jonathan E

AXL Is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer

AXL是细胞可塑性的关键因素,并促进胰腺癌转移

Wenting Du ,Natalie Z Phinney ,Huocong Huang ,Zhaoning Wang ,Jill Westcott ,Jason E Toombs ,Yuqing Zhang ,Muhammad S Beg ,Thomas M Wilkie ,James B Lorens ,Rolf A Brekken

NQO1-dependent, Tumor-selective Radiosensitization of Non-small Cell Lung Cancers

NQO1 依赖的非小细胞肺癌肿瘤选择性放射增敏

Edward A Motea #, Xiumei Huang #, Naveen Singh, Jessica A Kilgore, Noelle S Williams, Xian-Jin Xie, David E Gerber, Muhammad S Beg, Erik A Bey, David A Boothman

The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism

NQO1 生物活化药物 β-拉帕酮改变 NQO1+ 胰腺癌细胞的氧化还原状态,导致中心碳代谢紊乱

Molly A Silvers, Stanislaw Deja, Naveen Singh, Robert A Egnatchik, Jessica Sudderth, Xiuquan Luo, Muhammad S Beg, Shawn C Burgess, Ralph J DeBerardinis, David A Boothman, Matthew E Merritt